• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

霉酚酸在CD4+细胞中的药效学:健康个体中肌苷单磷酸脱氢酶和嘌呤核苷酸反应的单剂量研究。

Pharmacodynamics of mycophenolic acid in CD4+ cells: a single-dose study of IMPDH and purine nucleotide responses in healthy individuals.

作者信息

Vethe Nils Tore, Bremer Sara, Rootwelt Helge, Bergan Stein

机构信息

Department of Medical Biochemistry, Rikshospitalet University Hospital, Oslo, Norway.

出版信息

Ther Drug Monit. 2008 Dec;30(6):647-55. doi: 10.1097/FTD.0b013e31818955c3.

DOI:10.1097/FTD.0b013e31818955c3
PMID:18806697
Abstract

Mycophenolate mofetil is used in rejection prophylaxis after allograft transplantation. The highly variable pharmacokinetics and pharmacodynamics (PD) of the active moiety mycophenolic acid (MPA) render this drug attractive for therapeutic monitoring. The aim of this study was to characterize the exposure-response relationship for MPA to guide future strategies for individualized therapy based on PD monitoring. A single-dose (100, 250, 500, and 1000 mg mycophenolate mofetil) crossover exposure-response study of MPA PD in CD4 cells was performed in 5 healthy individuals. The activity of inosine 5'-monophosphate dehydrogenase (IMPDH) at time 0 ranged from 1.2 to 7.2 pmol per 10 cells/min. IMPDH was strongly inhibited by MPA; MPA EC50 (concentration required for 50% inhibition) of 2.3 mg/L was determined by a pooled data analysis. Decreased IMPDH gene expression was associated with the exposure to MPA. There were no immediate reductions of guanine nucleotides. On the contrary, a trend toward increased guanosine triphosphate was observed. IMPDH activity AUC0-12h approached maximum reduction at MPA AUC0-12h 22 mg x h/L (corresponding to the 500 mg dose), whereas plasma concentrations exceeding approximately 6 mg/L did not further increase the IMPDH inhibition. The results suggest that guanine nucleotides in circulating lymphocytes may not serve as immediate response biomarkers to MPA. Strategies for preventing over- or underexposure to MPA may be developed by means of IMPDH activity combined with MPA concentration measurement.

摘要

霉酚酸酯用于同种异体移植后的排斥反应预防。活性成分霉酚酸(MPA)高度可变的药代动力学和药效学(PD)使该药物成为治疗监测的理想选择。本研究的目的是表征MPA的暴露-反应关系,以指导基于PD监测的个体化治疗未来策略。在5名健康个体中进行了MPA PD的单剂量(100、250、500和1000 mg霉酚酸酯)交叉暴露-反应研究。0时刻肌苷5'-单磷酸脱氢酶(IMPDH)的活性范围为每10个细胞/分钟1.2至7.2 pmol。IMPDH受到MPA的强烈抑制;通过汇总数据分析确定MPA的EC50(50%抑制所需浓度)为2.3 mg/L。IMPDH基因表达的降低与MPA暴露有关。鸟嘌呤核苷酸没有立即减少。相反,观察到三磷酸鸟苷有增加的趋势。在MPA AUC0-12h为22 mg·h/L(对应于500 mg剂量)时,IMPDH活性AUC0-12h接近最大降低,而血浆浓度超过约6 mg/L并未进一步增加IMPDH抑制。结果表明,循环淋巴细胞中的鸟嘌呤核苷酸可能不是MPA的即时反应生物标志物。可以通过结合MPA浓度测量的IMPDH活性来制定预防MPA暴露过度或不足的策略。

相似文献

1
Pharmacodynamics of mycophenolic acid in CD4+ cells: a single-dose study of IMPDH and purine nucleotide responses in healthy individuals.霉酚酸在CD4+细胞中的药效学:健康个体中肌苷单磷酸脱氢酶和嘌呤核苷酸反应的单剂量研究。
Ther Drug Monit. 2008 Dec;30(6):647-55. doi: 10.1097/FTD.0b013e31818955c3.
2
Simultaneous quantification of IMPDH activity and purine bases in lymphocytes using LC-MS/MS: assessment of biomarker responses to mycophenolic acid.采用 LC-MS/MS 同时定量测定淋巴细胞中 IMPDH 活性和嘌呤碱:评估生物标志物对霉酚酸的反应。
Ther Drug Monit. 2014 Feb;36(1):108-18. doi: 10.1097/FTD.0b013e3182a13900.
3
Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.霉酚酸治疗期间从全血中分离的人CD4+细胞中肌苷单磷酸脱氢酶活性的测定。
Ther Drug Monit. 2006 Oct;28(5):608-13. doi: 10.1097/01.ftd.0000245680.38143.ca.
4
No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study.肾移植患者中泮托拉唑与霉酚酸之间无相关药代动力学相互作用:一项随机交叉研究。
Br J Clin Pharmacol. 2015 Nov;80(5):1086-96. doi: 10.1111/bcp.12664. Epub 2015 Jul 14.
5
Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study.霉酚酸在贝拉西普治疗的肾移植受者中的药代动力学和药效学——一项初步研究。
J Transl Med. 2009 Jul 27;7:64. doi: 10.1186/1479-5876-7-64.
6
Mycophenolate pharmacokinetics and inosine monophosphate dehydrogenase activity in liver transplant recipients with an emphasis on therapeutic drug monitoring.肝移植受者麦考酚酸药代动力学和肌苷单磷酸脱氢酶活性研究——重点关注治疗药物监测。
Scand J Clin Lab Invest. 2013 Mar;73(2):117-24. doi: 10.3109/00365513.2012.745947. Epub 2013 Jan 3.
7
Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment.霉酚酸酯治疗期间肾移植受者的肌苷单磷酸脱氢酶活性
Scand J Clin Lab Invest. 2006;66(1):31-44. doi: 10.1080/00365510500420259.
8
Inosine monophosphate dehydrogenase (IMPDH) activity as a pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipients.肌苷单磷酸脱氢酶(IMPDH)活性作为儿童肾移植受者麦考酚酸作用的药效学生物标志物。
J Clin Pharmacol. 2011 Mar;51(3):309-20. doi: 10.1177/0091270010368542. Epub 2010 Apr 23.
9
Expression of IMPDH1 is regulated in response to mycophenolate concentration.肌苷-5'-单磷酸脱氢酶1(IMPDH1)的表达受霉酚酸浓度的调控。
Int Immunopharmacol. 2009 Feb;9(2):173-80. doi: 10.1016/j.intimp.2008.10.017. Epub 2008 Nov 20.
10
Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy.长期应用霉酚酸酯治疗的肾移植患者中的肌苷单磷酸脱氢酶变异性。
Br J Clin Pharmacol. 2010 Jan;69(1):38-50. doi: 10.1111/j.1365-2125.2009.03542.x.

引用本文的文献

1
Pharmacodynamic assessment of mycophenolic acid in resting and activated target cell population during the first year after renal transplantation.肾移植后第一年静息和活化靶细胞群体中霉酚酸的药效学评估。
Br J Clin Pharmacol. 2020 Jun;86(6):1100-1112. doi: 10.1111/bcp.14218. Epub 2020 Feb 16.
2
Pharmacogenetics and immunosuppressive drugs in solid organ transplantation.药物遗传学与实体器官移植中的免疫抑制剂。
Nat Rev Nephrol. 2014 Dec;10(12):725-31. doi: 10.1038/nrneph.2014.172. Epub 2014 Sep 23.
3
Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study.
霉酚酸在贝拉西普治疗的肾移植受者中的药代动力学和药效学——一项初步研究。
J Transl Med. 2009 Jul 27;7:64. doi: 10.1186/1479-5876-7-64.